News Amicus Therapeutics Receives FDA Approval for Pombiliti + Opfolda in Late-Onset Pompe Disease by Warren Seah September 28, 2023 by Warren Seah September 28, 2023 By Chris Wack Shares of Amicus Therapeutics have been temporarily halted at $12.88 following the Food… Read more